Swedish Rectal Prolapse Trial

May 17, 2021 updated by: Klas Pekkari, Danderyd Hospital

To Resect or Not Resect - The Randomized Swedish Rectal Prolapse Trial

Rectal prolapse is a medical condition where rectum is protruding through the anal opening. The treatment is by surgery that can be performed with an anterior approach through the abdomen or a posterior perineal approach. The condition is more common in elderly patients and much more common in women compared to men. All used surgical techniques have advantages and disadvantages. The primary aim of this study is to evaluate if an abdominal or perineal surgical approach is best to correct a rectal prolapse. The outcome measures will be validated questionnaires on quality of Life (SF-36) and bowel function (modified Wexner incontinence score) as well as recurrence of the rectal prolapse and surgical complications.

The study is a randomized multicenter trial with a 2x2 factorial design. Patients will be randomized between perineal and abdominal approach in a first randomization and the perineal group will then further be randomized into one of two specific operations (delorme or altemeier) and the abdominal group will be further randomized into suture rectopexy or resection rectopexy.

The patients will be followed for 3 months, 1 year and 3 years and a longterm follow up of up to 17 years for recurrence.

Study Overview

Detailed Description

Background Full thickness rectal prolapse, or procidentia, is a benign but distressing condition. It is defined as the circumferential protrusion of all layers of the rectal wall through the anal sphincters. The annual incidence is 2,5 per 100 000, predominantly in the elderly, and male-to-female ratio is about 1:6.

More than 100 different procedures have been described for surgical treatment of rectal prolapse and consensus has not yet been reached. Traditionally, perineal procedures have been reserved for older patients who are not fit for an abdominal operation. The two most common perineal procedures are Delorme's operation, i.e. mucosectomy and rectal plication, and perineal rectosigmoidectomy, also known as Altemeier's operation, which is a full-thickness excision of the rectum.

The choices between abdominal vs. perineal approach and resection or not were all addressed in the Swedish rectal prolapse trial with possible differences in bowel function, quality of life, recurrence rate and complications as end points.

Study design and randomization This was a multicenter randomized trial with a 2 x 2 factorial design conducted in 13 sites in Sweden. At inclusion, patients signed an informed consent form and the attending surgeon contacted the central trial office at the Danderyd Hospital, Stockholm, Sweden. Randomization was performed with randomly assigned envelopes, stratified for each participating center. Patients were randomized between perineal and abdominal approach (A). The perineal group was further randomized to Delorme's or Altemeier's procedure (B) and the abdominal group to suture rectopexy or resection rectopexy (C). Patients who were considered unsuitable for random allocation to a perineal or an abdominal procedure were included only in (B) or (C).

Preoperative evaluation and procedures All patients were clinically examined and diagnosed with full thickness rectal prolapse. Further examinations with endoscopy, colon transit studies, anorectal manometry, defecography, endoanal ultrasound and pudendal nerve motor latency were optional and were performed as indicated at each surgeon's discretion. Operative procedures were described in the study protocol, see appendix. Abdominal procedures were performed laparoscopically or as open procedure.

In order to validate data all questionnaires were gathered at the central trial hospital and inspected by a second researcher.

The surgical procedures were identified and standardized to a large extent. Both minimal invasive and open surgery were allowed. For example the abdominal procedures were described that mobilization of rectum should be done in the posterior aspect, the lateral ligaments should not be divided, Suture rectopexy should be done with non-absorbable 0.0 sutures, the cul de sac should not be closed.

The sample size was calculated to 220 patients in the first randomization between abdominal and perineal approach. With 220 patients a difference in recurrence of 13% could be identified with 90% power in a significance level of 5%. The plan was to analyze the categorical variables with either Fisher´s exact test or multivariate analysis.

A main study office was situated at Danderyd Hospital and randomization was done from this office at the time when the patient was scheduled for surgery. All hospitals performing surgery for rectal prolapses in Sweden were invited to the study.

Study Type

Interventional

Enrollment (Actual)

134

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Gothenburg, Sweden
        • Sahlgrenska University Hospital
      • Karlstad, Sweden
        • Karlstad Central Hospital
      • Linköping, Sweden
        • Linkoping University Hospital
      • Luleå, Sweden
        • Sunderbyn Hopsital
      • Malmö, Sweden
        • Skåne University Hospital
      • Norrköping, Sweden
        • Vrinnevi Hospital
      • Stockholm, Sweden, 18150
        • Danderyd Hospital
      • Stockholm, Sweden
        • karolinska Univeristy Hospital Solna
      • Stockholm, Sweden
        • Karolinska University Hospital Huddiinge
      • Stockholm, Sweden
        • Sankt göran hospital
      • Uddevalla, Sweden
        • Uddevalla Hospital
      • Uppsala, Sweden
        • Uppsala University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Complete rectal prolapse
  2. Informed consent
  3. Surgical correction is considered appropriate
  4. Capable to participate in follow-up visits and answering questionnaires

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Abdominal suture rectopexy
Patients were randomized first into either an abdominal or a perineal approach. The abdominal group was then further randomized to suture rectopexy or resection rectopexy.
Active Comparator: Abdominal resection rectopexy
Patients were randomized first into either an abdominal or a perineal approach. The abdominal group was then further randomized to suture rectopexy or resection rectopexy.
Active Comparator: Perineal Delorme
Patients were randomized first into either an abdominal or a perineal approach. The perineal group was then further randomized to Delorme's operation or Altemeier's operation.
Active Comparator: Perineal Altemeier
Patients were randomized first into either an abdominal or a perineal approach. The perineal group was then further randomized to Delorme's operation or Altemeier's operation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bowel function
Time Frame: 3 months
Wexner incontinence score, points, 0-20, higher worse result
3 months
Bowel function
Time Frame: 1 year
Wexner incontinence score, points, 0-20, higher worse result
1 year
Bowel function
Time Frame: 3 years
Wexner incontinence score, points, 0-20, higher worse result
3 years
Quality of Life
Time Frame: 3 months
SF-36, points, 0-100 points, higher better result
3 months
Quality of Life
Time Frame: 1 year
SF-36, points, 0-100 points, higher better result
1 year
Quality of Life
Time Frame: 3 years
SF-36, points, 0-100 points, higher better result
3 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recurrence of rectal prolapse
Time Frame: 3 months
recurrence at outpatient visits
3 months
Recurrence of rectal prolapse
Time Frame: 1 year
recurrence at outpatient visits
1 year
Recurrence of rectal prolapse
Time Frame: 3 years
recurrence at outpatient visits
3 years
Recurrence of rectal prolapse
Time Frame: through study completion, an average of 12 years
Recurrence in Medical records
through study completion, an average of 12 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of staý
Time Frame: up to 30 days after surgical intervention
days
up to 30 days after surgical intervention
Blood loss at operation
Time Frame: during the surgical procedure
milliliter
during the surgical procedure
perioperative complications
Time Frame: up to 30 days after surgical intervention
number classified by Clavien-Dindo
up to 30 days after surgical intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Fredrik Hjern, Ass Prof, MD, Danderyd Hospital
  • Study Director: Klas Pekkari, Md PhD, Danderyd Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 23, 2000

Primary Completion (Actual)

June 1, 2018

Study Completion (Actual)

June 1, 2018

Study Registration Dates

First Submitted

April 27, 2021

First Submitted That Met QC Criteria

May 17, 2021

First Posted (Actual)

May 19, 2021

Study Record Updates

Last Update Posted (Actual)

May 19, 2021

Last Update Submitted That Met QC Criteria

May 17, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rectal Prolapse

Clinical Trials on Suture rectopexy

3
Subscribe